(RTTNews) - BriaCell Therapeutics Corp. (BCTX), a clinical-stage biotechnology company, on Monday announced the resolution of lung metastasis in the first patient treated with Bria-OTS, a ...

Introduction: Bone is a common metastatic site for small cell lung cancer (SCLC). Bone metastasis (BM) in patients have are known to show poor prognostic outcomes. We explored the epidemiological ...

Five students from Ouachita Baptist University’s Patterson School of Natural Sciences have published research in the ...

Feb. 6, 2025 — Despite new medication, cystic fibrosis often leads to permanent lung damage. Researchers have discovered that the disease causes changes in the immune system early in life ...

The heterogeneity of brain metastases highlights the differences from their primary source of origin ... Patients with lower baseline cognitive impairment or primary lung cancer might benefit more ...

“The lung cancer treatment landscape continues to rapidly evolve,” he adds. “In recent years ... of the 9th edition of the Tumour, Node and Metastasis (TNM) staging system, the most commonly ...

CAMBRIDGE, Mass. - Immuneering Corporation (NASDAQ:IMRX), a clinical-stage oncology company with a market capitalization of $59.31 million, has entered into a clinical supply agreement with Regeneron ...

Researchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...

While those are the most common sites for prostate cancer bone metastasis, any bones in your body could be a potential target. Prostate cancer can involve the liver, intestines, brain, lungs, and ...

Bradley Jay Kusler, 62, of Litchfield passed away peacefully Dec. 22 at Meeker Memorial Hospital in Litchfield. Funeral was Friday at Zion Lutheran Church in Litchfield with the Rev.

Professor Martin Röcken discusses challenges and opportunities in dermatology care, immunotherapy, the MDT and his hopes for ...